Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
GSK chief Emma Walmsley rounds out her top team with CFO pick — but performance lags
Endpoints
Tue, 08/7/18 - 11:26 am
GSK
Pharma CEOs
Emma Walmsley
[video+transcript]GlaxoSmithKline Makes a Big Bet on DNA
Motley Fool
Thu, 08/2/18 - 11:13 pm
GSK
23andMe
DNA sequencing
pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in
RAPS.org
Thu, 07/26/18 - 07:28 pm
Novartis
Merck
GSK
Gilead Sciences
Bayer
AstraZeneca
AbbVie
Takeda
FDA
DDIs
drug-drug interactions
proton pump inhibitors
Forget a consumer spinoff. GlaxoSmithKline is plotting a $525M cost-cutting drive instead
Fierce Pharma
Wed, 07/25/18 - 03:19 pm
GSK
Emma Walmsley
Drugs aimed at a sliver of Parkinson’s patients may benefit many more than thought — and boost a biotech
Stat
Wed, 07/25/18 - 03:15 pm
Parkinson's Disease
LRRK2
Pfizer
Denali Therapeutics
GSK
GSK bets $300 million on genetics as CEO plays down break-up talk
Yahoo/Reuters
Wed, 07/25/18 - 09:25 am
GSK
23andMe
Emma Walmsley
Glaxo’s New Research Chief Loves Big Pharma. Now He Has To Fix It
Forbes
Tue, 07/24/18 - 11:18 am
GSK
Hal Barron
R&D
Adaptimmune Completes Transition of Pioneering T-Cell Therapy to GSK – Will Receive $27 Million Payment
CP Wire
Tue, 07/24/18 - 10:54 am
Adaptimmune
GSK
GSK3377794
T-cells
Adaptimmune Completes Transition of Pioneering T-Cell Therapy to GSK – Will Receive $27 Million Payment
Tue, 07/24/18 - 10:17 am
Adaptimmune
GSK
GSK3377794
FDA staff raises efficacy doubts on GSK's lung disease treatment
Yahoo/Reuters
Mon, 07/23/18 - 09:38 am
GSK
FDA
Nucala
COPD
NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used
Fierce Pharma
Sun, 07/22/18 - 12:21 pm
AstraZeneca
Fasenra
GSK
Nucala
NICE
asthma
GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant
TheStreet.com
Sat, 07/21/18 - 01:24 pm
GSK
4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?
Motley Fool
Mon, 07/16/18 - 09:21 am
HIV
Gilead Sciences
Biktarvy
GSK
Triumeq
Genvoya
Tivicay
Dermavant inks $330M deal for GSK's phase 3-ready psoriasis drug
Fierce Biotech
Thu, 07/12/18 - 06:17 pm
GSK
Dermavant
Roivant
CSO
tapinarof
psoriasis
atopic dermatitis
Senators demand more from GlaxoSmithKline to boost Shingrix supply
Fierce Pharma
Fri, 07/6/18 - 10:15 am
GSK
vaccines
Shingrix
shingles
Senate
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
M&A
biotech
Celgene
Sanofi
Impact Biomedicines
Bioverativ
GSK
Takeda
Shire
JNJ
Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest
Endpoints
Thu, 07/5/18 - 11:22 am
Donald Trump
UK
Brexit
JNJ
GSK
Pharma CEOs
Alex Gorsky
Emma Walmsley
GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand
Fierce Pharma
Thu, 06/21/18 - 10:56 pm
GSK
Shingrix
shingles
vaccines
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Yahoo/Reuters
Wed, 06/20/18 - 09:28 am
GSK
Gilead Sciences
HIV
AIDS
Dolutegravir
lamivudine
Biktarvy
5 Experimental New Drugs That Could Be Worth $47 Billion
Motley Fool
Wed, 06/20/18 - 09:26 am
GSK2857916
GSK
brolucizumab
Novartis
aducanumab
Biogen
upadacatinib
AbbVie
VX-659 + tezacaftor + ivacaftor
Vertex Pharmaceuticals
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »